| COVID-19 |
1 |
1 |
| Severe Acute Respiratory Syndrome |
0 |
0.74 |
| Acute Respiratory Distress Syndrome |
0 |
0.48 |
| Pancreas |
0 |
0.99 |
| Pandemic |
0 |
0.32 |
| Metabolism |
0 |
0.26 |
| Hyperglycemia |
0 |
0.16 |
| Insulin Resistance |
0 |
0.16 |
| Blood |
0 |
0.1 |
| Stress |
0 |
0.1 |
| Type 2 Diabetes Mellitus |
0 |
0.1 |
| Healthcare and Medical Technology |
0 |
0.07 |
| Type 1 Diabetes Mellitus |
0 |
0.07 |
| Assisted Ventilation |
0 |
0.05 |
| Child |
0 |
0.05 |
| COVID-19 and Diabetes |
0 |
0.98 |
| Cytokines |
0 |
0.05 |
| Diabetic Ketoacidosis |
0 |
0.05 |
| Endocrinology |
0 |
0.05 |
| Healthcare Personnel (HCP) |
0 |
0.05 |
| Hospital |
0 |
0.05 |
| Lung |
0 |
0.05 |
| Medical Innovations |
0 |
0.05 |
| Nutrition |
0 |
0.05 |
| Physiology |
0 |
0.05 |
| Receptors |
0 |
0.05 |
| Respiratory Tract Infections |
0 |
0.05 |
| Viral Infection |
0 |
0.05 |
| Abdominal Infection |
0 |
0.03 |
| Mechanical Ventilation |
0 |
0.03 |
| Pancreatitis |
0 |
0.03 |
| Telehealth and Telemedicine |
0 |
0.03 |